Press Releases

ANAHEIM, Calif., April 1, 2008 — Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, has introduced a new surgical gown made from a unique and proprietary fabric that is softer to the skin than other surgical gowns, improving comfort for clinicians. The announcement was made today at the 55th Annual Congress for the Association of periOperative Registered Nurses (AORN).

The new RoyalSilk™ surgical gown expands Cardinal Health’s infection prevention apparel line and offers the additional benefits of improved comfort for operating room staff. Intended for general procedures that involve moderate to minimal fluid, the RoyalSilk™ gown provides AAMI Level 3 protection from blood, liquid and other potentially infectious material.

Surgical gowns are designed to protect patients from contaminants that health care workers may carry and safeguard the surgical team from infection by shielding them from blood, liquid and other potentially infectious material that can carry viruses and bacteria from one area to another.

“Customers have long been asking for a surgical gown that places softness and comfort on the same level of importance as protection and safety,” said Debra Schotz, Cardinal Health’s vice president of marketing for Convertors® products. “The RoyalSilk™ gown achieves this balance by draping the wearer in breathable softness and providing the protection the surgical team counts on. We worked extensively with surgeons and nurses on designing and testing this new offering, and we believe customers will be very receptive to this.”

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing health care-associated infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing systems, MedMined™ electronic infection surveillance service, VIASYS® respiratory care products and the CareFusion™ patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at www.cardinalhealth.com.